International Flavors & Fragrances
About: International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.
Employees: 21,500
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
267% more call options, than puts
Call options by funds: $322M | Put options by funds: $87.8M
33% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 67
6% more capital invested
Capital invested by funds: $22.7B [Q2] → $24B (+$1.25B) [Q3]
2% more funds holding
Funds holding: 760 [Q2] → 773 (+13) [Q3]
8% more repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 266
4.1% less ownership
Funds ownership: 93.39% [Q2] → 89.29% (-4.1%) [Q3]
20% less funds holding in top 10
Funds holding in top 10: 20 [Q2] → 16 (-4) [Q3]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Barclays Lauren Lieberman 43% 1-year accuracy 39 / 90 met price target | 3%upside $88 | Equal-Weight Maintained | 17 Jan 2025 |
Citigroup Patrick Cunningham 41% 1-year accuracy 13 / 32 met price target | 23%upside $105 | Buy Maintained | 18 Dec 2024 |
Morgan Stanley Lisa De Neve 67% 1-year accuracy 2 / 3 met price target | 29%upside $110 | Overweight Upgraded | 12 Nov 2024 |
JP Morgan Jeffrey Zekauskas 36% 1-year accuracy 16 / 44 met price target | 25%upside $107 | Overweight Maintained | 7 Nov 2024 |
Vertical Research | 27%upside $109 | Buy Upgraded | 7 Nov 2024 |